Partners
Founding partner programme
Strategic partnerships for pharma, biotech, investors, academic groups and data providers building mechanistic AI-QSP assets.
Engagement options
- Platform subscription and model access
- Co-development sprints for priority programmes
- Custom model build and validation
- Regulatory strategy input and documentation
- Optional therapeutic-area exclusivity windows
Who benefits most?
Portfolios with 10–30 active programmes, heavy Phase I/II decision loads and strong data assets seeking interpretability without sacrificing speed.
Become a partner →